Clinical Trials Directory

Trials / Sponsors / Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.
Healthy Volunteer
Phase 12025-10-07
Active Not RecruitingStudy to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera
Polycythemia Vera
Phase 32024-01-22
Active Not RecruitingA Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Polycythemia Vera
Phase 32022-04-01
CompletedPharmacokinetics of PN-232 in Healthy Volunteers
Healthy Subjects
Phase 12021-05-13
CompletedPTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Polycythemia Vera
Phase 22021-02-02
CompletedPharmacokinetics of PN-235 in Healthy Volunteers
Healthy Volunteers
Phase 12020-11-12
CompletedPharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers
Healthy Volunteers
Phase 12020-09-14
CompletedPN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe
Phase 22020-08-05
CompletedPTG-300 in Subjects With Hereditary Hemochromatosis
Hereditary Hemochromatosis
Phase 22020-03-19
CompletedHepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Polycythemia Vera
Phase 22019-10-01
CompletedSafety Study for Beta Thalassemia Subjects on PTG-300
β-thalassemia, Ineffective Erythropoiesis
Phase 22019-05-10
CompletedStudy of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic
β-thalassemia, Ineffective Erythropoiesis, Chronic Anemia
Phase 22018-12-19
TerminatedSafety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
Ulcerative Colitis
Phase 22016-12-01